BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 6209486)

  • 1. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
    Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
    J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
    J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new inotropic drugs.
    Carlier J; el Allaf D
    Resuscitation; 1984 Mar; 11(3-4):217-31. PubMed ID: 6144152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenalterol--a new cardioselective inotropic agent.
    Kendall MJ; Goodfellow RM; Westerling S
    J Clin Hosp Pharm; 1982 Jun; 7(2):107-18. PubMed ID: 7050180
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.